Commonwealth Equity Services’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-12,955
| Closed | -$54K | – | 3760 |
|
|
2021
Q3 | $54K | Buy |
12,955
+75
| +0.6% | +$313 | ﹤0.01% | 3494 |
|
|
2021
Q2 | $68K | Buy |
12,880
+95
| +0.7% | +$502 | ﹤0.01% | 3440 |
|
|
2021
Q1 | $59K | Sell |
12,785
-687
| -5% | -$3.17K | ﹤0.01% | 3321 |
|
|
2020
Q4 | $44K | Sell |
13,472
-220
| -2% | -$719 | ﹤0.01% | 3138 |
|
|
2020
Q3 | $45K | Sell |
13,692
-1,500
| -10% | -$4.93K | ﹤0.01% | 2953 |
|
|
2020
Q2 | $51K | Sell |
15,192
-400
| -3% | -$1.34K | ﹤0.01% | 2848 |
|
|
2020
Q1 | $59K | Sell |
15,592
-3,200
| -17% | -$12.1K | ﹤0.01% | 2661 |
|
|
2019
Q4 | $113K | Buy |
18,792
+700
| +4% | +$4.21K | ﹤0.01% | 2727 |
|
|
2019
Q3 | $136K | Buy |
18,092
+4,600
| +34% | +$34.6K | ﹤0.01% | 2632 |
|
|
2019
Q2 | $182K | Buy |
+13,492
| New | +$182K | ﹤0.01% | 2528 |
|
|
2019
Q1 | – | Sell |
-14,420
| Closed | -$42K | – | 2794 |
|
|
2018
Q4 | $42K | Buy |
+14,420
| New | +$42K | ﹤0.01% | 2577 |
|